What Turning Point Brands, Inc. told the SEC could break it.

As a tobacco and alternative-products company, Turning Point Brands is subject to the FDA's tobacco regulatory regime under the Tobacco Control Act, including the cost-intensive premarket tobacco product application (PMTA) process for newly deemed products (vapor/NewGen, MYO, etc.) and prospective good-manufacturing-practice rules. The company flags that the FDA could promulgate GMP regulations for its products — and has indicated it intends to do so — which could have a material adverse impact on its ability and cost to manufacture. PMTA denials, flavor restrictions, or new GMP requirements could remove products from the market or raise compliance costs. A business-critical regulatory exposure for the tobacco sector.

“The FDA could in the future promulgate good manufacturing practice regulations for these and our other products, and indeed has indicated it intends to do so, which could have a material adverse impact on our ability and the cost to manufacture our products.”

Turning Point Brands imports key products — notably Zig-Zag premium papers and cigar wraps sourced via French partner RTI — and import tariffs have already hit results: 2025 gross margin fell to 53.7% from 55.4%, driven primarily by Zig-Zag cigar-wrap margins due to imposed tariffs (and product-mix shift). It notes that IEEPA tariffs it previously paid carry no refund mechanism (uncertain whether/how much will be refunded) and that, following a court ruling, the administration imposed a blanket 10% tariff under Section 122 of the Trade Act of 1974. Because its flagship Zig-Zag supply is imported, escalating tariffs directly raise COGS and compress margins. A specific, already-materialized trade-policy exposure central to the supply-shock thesis.

“driven primarily by Zig-Zag cigar wraps margins due to imposed tariffs and a shift in product mix with an increase in products with lower margins in the segment.”

Turning Point Brands runs an asset-light, distribution-focused model: approximately 75% of its production (as measured by net sales) is outsourced to suppliers, and it depends on a small number of key third-party suppliers and producers for its products. Its two flagship lines are each made/supplied by a single named partner — Republic Technology International (RTI) for Zig-Zag premium papers and Swedish Match/Philip Morris International for loose-leaf chewing tobacco (both captured as supply edges) — with only its moist-snuff operations (Dresden, TN and Louisville, KY) produced in-house (<25% of net sales). A disruption, price action or termination by a key supplier would directly impair its largest product lines. A real supplier-concentration / outsourced-production dependence.

“Approximately 75% of our production, as measured by net sales, is outsourced to suppliers.”